Oaktree Specialty Lending (NASDAQ:OCSL – Get Rating)‘s stock had its “market outperform” rating reiterated by research analysts at JMP Securities in a note issued to investors on Monday, Benzinga reports. They currently have a $23.00 price target on the credit services provider’s stock. JMP Securities’ price objective would indicate a potential upside of 25.89% from the company’s current price.
A number of other equities analysts also recently weighed in on the company. Wells Fargo & Company upped their target price on Oaktree Specialty Lending from $21.00 to $22.50 and gave the company an “overweight” rating in a report on Wednesday, November 16th. StockNews.com raised shares of Oaktree Specialty Lending from a “sell” rating to a “hold” rating in a research note on Tuesday, January 10th. B. Riley upped their target price on Oaktree Specialty Lending from $18.75 to $22.50 and gave the stock a “buy” rating in a research report on Wednesday, November 16th. JPMorgan Chase & Co. dropped their target price on Oaktree Specialty Lending from $21.00 to $20.50 and set an “overweight” rating on the stock in a research report on Wednesday, February 8th. Finally, Hovde Group set a $22.50 target price on Oaktree Specialty Lending in a research report on Thursday, November 17th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $22.20.
Oaktree Specialty Lending Stock Up 2.3 %
OCSL stock opened at $18.27 on Monday. The firm has a market capitalization of $1.41 billion, a P/E ratio of 464.00 and a beta of 1.19. The company’s 50 day simple moving average is $20.40 and its 200-day simple moving average is $20.17. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.08 and a quick ratio of 0.08. Oaktree Specialty Lending has a 52-week low of $17.59 and a 52-week high of $22.83.
Institutional Trading of Oaktree Specialty Lending
A number of institutional investors and hedge funds have recently modified their holdings of the company. Bruni J V & Co. Co. lifted its stake in shares of Oaktree Specialty Lending by 1.0% in the fourth quarter. Bruni J V & Co. Co. now owns 4,570,564 shares of the credit services provider’s stock worth $31,400,000 after buying an additional 44,051 shares during the last quarter. Lindbrook Capital LLC grew its position in shares of Oaktree Specialty Lending by 0.3% in the fourth quarter. Lindbrook Capital LLC now owns 4,163,356 shares of the credit services provider’s stock valued at $28,602,000 after purchasing an additional 11,039 shares during the last quarter. LSV Asset Management grew its position in shares of Oaktree Specialty Lending by 1.8% in the fourth quarter. LSV Asset Management now owns 3,756,136 shares of the credit services provider’s stock valued at $25,805,000 after purchasing an additional 65,410 shares during the last quarter. CLARET ASSET MANAGEMENT Corp grew its position in shares of Oaktree Specialty Lending by 1.0% in the fourth quarter. CLARET ASSET MANAGEMENT Corp now owns 3,102,562 shares of the credit services provider’s stock valued at $21,315,000 after purchasing an additional 31,740 shares during the last quarter. Finally, Partners Group Holding AG lifted its holdings in shares of Oaktree Specialty Lending by 6.5% during the second quarter. Partners Group Holding AG now owns 2,774,503 shares of the credit services provider’s stock worth $18,173,000 after buying an additional 169,006 shares during the last quarter. 50.26% of the stock is currently owned by institutional investors and hedge funds.
Oaktree Specialty Lending Company Profile
Oaktree Specialty Lending Corp. operates as an alternative asset manager that provides financing solutions to private, small and mid-sized growing businesses. While fostering growth is our primary mission, a singular purpose drives all of our pursuits partnering for success.
See Also
- Get a free copy of the StockNews.com research report on Oaktree Specialty Lending (OCSL)
- Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
- GitLab Crashes On Guidance; Analysts Defend
- Healthcare Stocks With at Least 30 Years of Dividend Increases
- Coinbase Pops As SVB Crumbles To Dust
- Airlines Update Guidance, Shares Head For Different Destinations
Receive News & Ratings for Oaktree Specialty Lending Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oaktree Specialty Lending and related companies with MarketBeat.com's FREE daily email newsletter.